Latest Clinical Trials news
About One-Third Eligible for Weight Loss Drugs Meet Trial Exclusion Criteria
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
2008 to 2022 Saw Rise in Industry-Sponsored Adult Cancer Clinical Trials
posted October 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes
posted September 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors Related Articles
.jpeg)
Most Adults With Moderate-to-Severe Ulcerative Colitis Ineligible for RCTs 
Huge Gap Exists Between Regulatory Authorization, Clinical Validation of AI Medical Devices 
Randomized Trial of Early Vitrectomy Feasible for Postoperative Endophthalmitis .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV Monthly Specialist Briefings
Stay Connected
